{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:01:00Z","timestamp":1773662460602,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol"],"DOI":"10.1186\/1471-2210-3-12","type":"journal-article","created":{"date-parts":[[2003,9,27]],"date-time":"2003-09-27T06:58:21Z","timestamp":1064645901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension"],"prefix":"10.1186","volume":"3","author":[{"given":"Amy KL","family":"Banes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie W","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,9,15]]},"reference":[{"key":"46_CR1","first-page":"1179","volume":"291","author":"A Banes","year":"1999","unstructured":"Banes A, Florian JA, Watts SW: Mechanisms of 5-hydroxytryptamine2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther. 1999, 291: 1179-1187.","journal-title":"J Pharmacol Exp Ther"},{"key":"46_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1476-5381.1996.tb15760.x","volume":"119","author":"MR MacLean","year":"1996","unstructured":"MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I: 5-hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol. 1996, 119: 917-930.","journal-title":"Br J Pharmacol"},{"key":"46_CR3","first-page":"143","volume":"272","author":"DA Cox","year":"1995","unstructured":"Cox DA, Cohen ML: 5-hydroxytryptamine2B receptor signaling in rat stomach fundus: role of voltage-dependent calcium channels, intracellular calcium release and protein kinase C. J Pharmacol Exp Ther. 1995, 272: 143-150.","journal-title":"J Pharmacol Exp Ther"},{"key":"46_CR4","first-page":"H944","volume":"276","author":"SW Watts","year":"1999","unstructured":"Watts SW, Fink GD: 5-HT2B-receptor antagonist LY272015 is antihypertensive in DOCA-salt hypertensive rats. Am J Physiol. 1999, 276: H944-H952.","journal-title":"Am J Physiol"},{"key":"46_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0306-3623(99)00040-3","volume":"33","author":"SW Watts","year":"1999","unstructured":"Watts SW, Harris B: Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate-salt treated rats blood pressure dependent?. Gen Pharm The Vasc Sys. 1999, 33: 439-447. 10.1016\/S0306-3623(99)00040-3.","journal-title":"Gen Pharm The Vasc Sys"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1476-5381.1993.tb13615.x","volume":"109","author":"DA Craig","year":"1993","unstructured":"Craig DA, Martin GR: 5-HT1B receptors mediate potent contractile responses to 5-HT in rat caudal artery. Br J Pharmacol. 1993, 109: 609-611.","journal-title":"Br J Pharmacol"},{"key":"46_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/sj.bjp.0701929","volume":"124","author":"R Verheggen","year":"1998","unstructured":"Verheggen R, Hundeshagen AG, Brown AM, Schindler M, Kaumann AJ: 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. Br J Pharmacol. 1998, 124: 1345-1354.","journal-title":"Br J Pharmacol"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.bjp.0702647","volume":"127","author":"F Lovern","year":"1999","unstructured":"Lovern F, Li XF, Lytton J, Triggle C: Functional characterization of mRNA expression of 5-HT receptors mediating contraction in human umbilical artery. Br J Pharmacol. 1999, 127: 1247-1255.","journal-title":"Br J Pharmacol"},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/sj.bjp.0702841","volume":"128","author":"I Morecroft","year":"1999","unstructured":"Morecroft I, Heeley RP, Prentice HM, Kirk A, MacLean MR: 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor. Br J Pharmacol. 1999, 128: 730-734.","journal-title":"Br J Pharmacol"},{"key":"46_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0014-2999(99)00114-4","volume":"372","author":"T Nilsson","year":"1999","unstructured":"Nilsson T, Longmore J, Shaw D, Pantev E, Bard JA, Branchek T, Edvinsson L: Characterization of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol. 1999, 372: 49-56. 10.1016\/S0014-2999(99)00114-4.","journal-title":"Eur J Pharmacol"},{"key":"46_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/hy1001.091779","volume":"38","author":"AK Banes","year":"2001","unstructured":"Banes AK, Watts SW: Enhanced contraction to 5-HT is not due to \"unmasking\" of 5-HT1B receptors in the mesenteric artery of the DOCA-salt rat. Hypertension. 2001, 38: 891-895.","journal-title":"Hypertension"},{"key":"46_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/hh2401.100426","volume":"89","author":"A Keegan","year":"2001","unstructured":"Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR: Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT1B receptor knockout mice and the 5-HT1B\/1D receptor antagonist GR127935. Circ Res. 2001, 89: 1231-1239.","journal-title":"Circ Res"},{"key":"46_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1161\/hy02t2.102793","volume":"39","author":"AK Banes","year":"2002","unstructured":"Banes AK, Watts SW: Upregulation of arterial serotonin1B and 2B receptors in deoxycorticosterone acetate-salt hypertension. Hypertension. 2002, 39: 394-398. 10.1161\/hy02t2.102793.","journal-title":"Hypertension"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nm764","volume":"8","author":"JM Launay","year":"2002","unstructured":"Launay JM, Herve P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L: Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nature Medicine. 2002, 8: 1129-1135. 10.1038\/nm764.","journal-title":"Nature Medicine"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/01.HYP.10.2.176","volume":"10","author":"V Sciotti","year":"1987","unstructured":"Sciotti V, Gallant S: Resistance to mineralocorticoid hypertensive vascular disease. Hypertension. 1987, 10: 176-180.","journal-title":"Hypertension"},{"key":"46_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1124\/jpet.102.037390","volume":"303","author":"A Russell","year":"2002","unstructured":"Russell A, Banes AK, Berlin H, Fink GD, Watts SW: 5-hydroxytryptamine2B receptor function is enhanced in the N\u03c9-L-arginine hypertensive rat. J Pharmacol Exp Ther. 2002, 303: 179-187. 10.1124\/jpet.102.037390.","journal-title":"J Pharmacol Exp Ther"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/00005344-200110000-00006","volume":"38","author":"SW Watts","year":"2001","unstructured":"Watts SW, Yang P, Banes AK, Baez M: Activation of ERK mitogen-activated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol. 2001, 38: 539-551. 10.1097\/00005344-200110000-00006.","journal-title":"J Cardiovasc Pharmacol"},{"key":"46_CR18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1242\/dev.124.9.1745","volume":"124","author":"DS Choi","year":"1997","unstructured":"Choi DS, Ward SJ, Messaddeq N, Launay JM, Maroteaux L: 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest cells and myocardiac cells. Development. 1997, 124: 1745-1755.","journal-title":"Development"},{"key":"46_CR19","doi-asserted-by":"publisher","first-page":"9508","DOI":"10.1073\/pnas.97.17.9508","volume":"97","author":"CG Nebigil","year":"2000","unstructured":"Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay JM, Maroteaux L: Serotonin2B receptor is required for heart development. Pro Natl Acad Sci USA. 2000, 97: 9508-9513. 10.1073\/pnas.97.17.9508.","journal-title":"Pro Natl Acad Sci USA"},{"key":"46_CR20","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1161\/01.CIR.103.24.2973","volume":"103","author":"CG Nebigil","year":"2001","unstructured":"Nebigil CG, Hickel P, Messaddeq N, Vonesch JL, Douchet MP, Monassier L, Gyorgy K, Matz R, Andriantsitohaina R, Manivet P, Launay JM, Maroteaux L: Ablation of serotonin 5-HT2B receptors in mice leads to abnormal cardiac structure and function. Circulation. 2001, 103: 2973-2979.","journal-title":"Circulation"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1476-5381.1996.tb15304.x","volume":"117","author":"GA Kennett","year":"1996","unstructured":"Kennett GA, Bright F, Trail B, Baxter GS, Blackburn TP: Tests of the 5-HT2B receptor agonist, BW723C86, on three rat models of anxiety. Br J Pharmacol. 1996, 117: 1443-1448.","journal-title":"Br J Pharmacol"}],"container-title":["BMC Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2210-3-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:12:37Z","timestamp":1726240357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/1471-2210-3-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,15]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1186\/1471-2210-3-12","relation":{},"ISSN":["1471-2210"],"issn-type":[{"value":"1471-2210","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,15]]},"assertion":[{"value":"25 June 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}